Melissa Mercincavage
Research Assistant Professor of Psychiatry
Member, Tobacco and Environmental Carcinogenesis Program, Abramson Cancer Center
Department: Psychiatry
Contact information
3535 Market St., Ste. 4100
Philadelphia, PA 19104
Philadelphia, PA 19104
Office: 215-746-7285
Publications
Education:
BS (Psychology)
University of Pittsburgh, 2008.
MS (Biobehavioral Health)
The Pennsylvania State University, 2012.
PhD (Biobehavioral Health)
The Pennsylvania State University, 2015.
BS (Psychology)
University of Pittsburgh, 2008.
MS (Biobehavioral Health)
The Pennsylvania State University, 2012.
PhD (Biobehavioral Health)
The Pennsylvania State University, 2015.
Post-Graduate Training
Postdoctoral Fellowship in Tobacco Regulatory Science, Center for Interdisciplinary Research on Nicotine Addiction, University of Pennsylvania, 2015-2018.
Permanent linkPostdoctoral Fellowship in Tobacco Regulatory Science, Center for Interdisciplinary Research on Nicotine Addiction, University of Pennsylvania, 2015-2018.
Description of Research Expertise
tobacco regulatory science, smoking topography, experimental research, nicotine dependence, nicotine reduction, tobacco product marketingSelected Publications
Sidhu AK, Johnson AC, Souprountchouk V, Wackowski O, Strasser AA, Mercincavage M: Cognitive and emotional responses to pictorial warning labels and their association with quitting measures after continued exposure. Addictive Behaviors 124: 107121, January 2022.Pearson JL, Watanabe M, Sanchez J, Mann S, Drake C, Mercincavage M: The “organic” descriptor and its association with cigarette health risk expectancies, subjective effects, and smoking topography: a pilot human laboratory study. Nicotine & Tobacco Research 24(1): 69-76, January 2022.
Mercincavage M, Pacek LR, Thrasher JF, Cappella JN, Delnevo C, Donny EC, & Strasser AA: Effects of advertising features on smokers’ and non-smokers’ perceptions of a reduced nicotine cigarette modified risk tobacco product. Tobacco Control 32(1): 6-12, January 2023.
Mercincavage M, Karelitz JL, Kreider CL, Souprountchouk V, Albelda B, Strasser AA: Comparing video observation to electronic topography device as a method of measuring cigarette puffing behavior. Drug and Alcohol Dependence 221: 108623, April 2021.
Mercincavage M, Albelda BF, Mays D, Souprountchouk V, Giovenco DP, Audrain-McGovern J, Strasser AA: Shedding ‘light’ on cigarette pack design: colour differences in product perceptions, use, and exposure following the U.S. descriptor ban. Tobacco Control 31(1): 19-24, January 2022.
Caroll DM, Denlinger-Apte RL, Dermody SS, King JL, Mercincavage M, Pacek LR, Smith TT, Tripp HL, White CM: Polarization within the field of tobacco and nicotine science and its potential impact on trainees. Nicotine & Tobacco Research 23(1): 36-39, January 2020.
Mercincavage M, Lochbuehler K, Wileyto EP, Benowitz NL, Tyndale RF, Lerman C, Strasser AA: Associations of reduced nicotine content cigarettes with smoking behaviors and biomarkers of exposure among slow and fast nicotine metabolizers. JAMA Network Open 1(4): e181346, August 2018.
Mercincavage M, Lochbuehler K, Villanti AC, Wileyto EP, Audrain-McGovern J, Strasser AA: Examining risk perceptions among daily smokers naïve to reduced nicotine content cigarettes. Nicotine & Tobacco Research 21(7): 985-990, July 2019.
Mercincavage M, Saddleson ML, Gup E, Halstead A, Mays D, Strasser AA: Reduced nicotine content cigarette advertising: How false beliefs and subjective ratings affect smoking behavior. Drug and Alcohol Dependence 173: 99-106, April 2017.
Mercincavage M, Wileyto EP, Saddleson ML, Lochbuehler K, Donny EC, Strasser AA: Attrition during a randomized controlled trial of reduced nicotine content cigarettes as a proxy for understanding acceptability of nicotine product standards. Addiction 112(6): 1095-1103, June 2017.